Vigamox Treatment for Ocular Graft-Versus-Host Disease

NCT04204122 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator decided to close study

Conditions

Ocular Graft-versus-host Disease

Interventions

DRUG: Vigamox
DRUG: Placebo

Sponsor

Washington University School of Medicine